Filter
102
Filtered Results: 102
Text search:
sinopharm
Featured
Recommendations
9
New Publications
2
Language
Document type
Guidelines
34
Studies & Reports
24
Fact sheets
14
Manuals
12
No document type
6
Situation Updates
5
Strategic & Response Plan
4
Resource Platforms
2
Infographics
1
Countries / Regions
Argentina
14
Brazil
6
Senegal
5
Global
4
Paraguay
4
Ukraine
3
Mozambique
3
Germany
3
West and Central Africa
3
East and Southern Africa
3
Colombia
2
Kenya
2
Rwanda
2
Chile
2
Syria
2
Nigeria
2
Latin America and the Carribbean
2
Middle East and North Africa
2
Switzerland
1
El Salvador
1
Benin
1
Congo-Brazzaville
1
Peru
1
Zimbabwe
1
Austria
1
Africa
1
Guinea-Bissau
1
Tanzania
1
South–East Asia Region
1
Namibia
1
Ethiopia
1
Angola
1
Chad
1
Ecuador
1
Authors & Publishers
Publication Years
Category
COVID-19
46
Guidelines
17
Studies & Reports
10
Policies
5
Policies & Guidelines HIV & TB
3
Women & Child Health
3
Pediatrics
2
Medical Devices & Equipment
2
Information, Education and Communication (IEC)
2
Hepatitis
1
Non-communicable Diseases NCD
1
Vaccine-preventable Diseases
1
Demograhic Health Surveys DHS
1
Drugs & Medical Equipment
1
Community Health
1
Capacity Building
1
Humanitarian Crisis
1
Statistics
1
Health Systems
1
Protection & Security
1
Non-communicable Diseases
1
Pharmacy & Technologies
1
Toolboxes
Country specific documents
35
Immunization Guidelines
7
Inactivated COVID-19 Vaccines
7
Booster Doses
6
Hospital Readiness/Essential Health Services
5
Communication Material
4
Essential Medicines
4
Infection Control General
3
For General Public & Community
3
Educational Settings
3
Workplace
3
Physical Distancing
3
Vaccine Hesitancy & Myths
3
Biontech/Pfizer Comirnaty
3
Vaccination
2
Clinical Guidelines
2
For Pregnant Women
2
Global Impact: Socio-economic, health services, TB & HIV
2
Infection Control & Prevention (IPC)
2
Access & Strategy
2
Moderna
2
Johnson & Johnson
2
Prices and Patents
2
Argentina
2
Accessibility
1
Inclusion in Humanitarian Settings
1
Pediatrics
1
Policies
1
SOPs
1
Situation Reports & Updates
1
Prevention & Preparedness
1
General
1
Public Health
1
Poster & Infographics
1
COVID-19 Information
1
For Parents & Children
1
Appeals and Response Plans
1
Dashboards & Maps
1
Country-specific Platforms
1
Paediatrics
1
HIV and COVID-19
1
COVID-19 Vaccination
1
Non-pharmaceutical interventions (NPIs)
1
Dashboards & Resource Platforms
1
Logistics & Supply
1
Fair Allocation & Ethical Aspects
1
Vaxzevria (Astra Zeneca)
1
Sputnik V
1
Research & Pipeline
1
Sanitation
1
Peru
1
Pharmacy Practice
1
Waste Managment
1
Reports & Studies
1
Situation Reports & Updates
1
Guidelines & Manuals
1
Information Refugees Ukraine
1
WASH Water Sanitation & Hygiene
1
General
1
COVID-19
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Global Overview
1
Detection & Diagnosis
1
Drug resistant TB
1
Policies and guidelines
1
Situation Reports & Updates
1
Human Rights & the Right to Health
1
Research & Access
1
HIV service delivery
1
La dosis de refuerzo está indicada una vez transcurridos los 4 meses (120 días) de la última dosis del esquema inicial y será con vacuna de plataforma ARNm: Pfizer-BioNTech pediátrica a partir de los 5 años o Moderna para uso pediátrico a partir de los 6 años.
Bisher hat die STIKO empfohlen, dass alle im Ausland mit einem nicht in der EU zugelassenen Impfstoff geimpften Personen eine erneute Impfserie mit einem in der EU zugelassenen Impfstoff erhalten sollen. Ziel der im Epidemiologischen Bulletin 13/2022 veröffentlichten aktualisierten COVID-19-Impfemp...
Wenn geflüchtete Menschen aus Kriegs- oder Krisengebieten, wie der Ukraine, nach Deutschland kommen, sollten ihnen frühzeitig alle Impfungen angeboten werden, die die Ständige Impfkommission (STIKO) für die in Deutschland lebende Bevölkerung empfiehlt. Ein aktueller Impfschutz ist entscheidend,...
Available in different languages
This resource explains how WHO EUL COVID-19 vaccines without vaccine vial monitor or VVM should be handled at the vaccination site, to ensure that safe and potent vaccines are administered.
This document has been updated: 31 August 2021
Introduction: Considering the global prevalence of coronavirus disease 2019 (COVID-19), a vaccine is being developed to control the disease as a complementary solution to hygiene measures—and better, in social terms, than social distancing. Given that a vaccine will eventually be produced, informa...
This report describes findings from a telephone survey with 1,333 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households with access to a landline or cell phone, but does n...
Child and adolescent vaccine safety report
This report on the safety of COVID-19 vaccination in children and adolescents in Argentina includes data from the start of the adolescent campaign
in Argentina, includes data reported since the start of the campaign in adolescents (28 July 2021) and in ch...
Additional dose of the primary vaccination against COVID-19: Technical Guidelines
This report describes findings from a telephone survey with 1,284 people conducted in February 2021. The survey examined how people respond to public health and social measures (PHSMs) to prevent COVID-19. The sample is representative of households with access to a landline or cell phone, but does n...
Policy Brief
HIV testing services
December 2016
WHO/HIV/2016.21
La troisième génération de la Stratégie de Coopération de l’OMS avec les Pays (SCP) concrétise le programme majeur de réforme adopté par l’Assemblée mondiale de la Santé pour renforcer la capacité de l’OMS et faire en sorte que ses prestations répondent mieux aux besoins du pays. E...
